February 2013 | OncologyLive

EGFR's Evolution: New Insights Refine Role of Mutation in NSCLC

March 01, 2013

Despite all we have learned about the importance of sensitizing EGFR mutations in defining the management of advanced NSCLC, our education regarding the relevance of this molecular target in optimizing clinical outcomes continues.